Datasheet | April 14, 2023

Milliflex® Rapid System 2.0 For Rapid Sterility And Bioburden Testing

Updated Milliflex Feature

Learn about the Milliflex® Rapid System 2.0, an automated solution for the rapid detection, imaging, and quantification of viable microbial contaminants in filterable samples throughout the manufacturing process. Its earlier results help to improve process control, product yield, and the timely release of final products. In case of contamination, corrective action can be taken much earlier, avoiding loss of time, money, and production capacity.

Proven technologies: The method is based on membrane filtration and ATP bioluminescence, two proven technologies. As today’s standard for preparing samples for microbial detection, membrane filtration is the methodology that worldwide pharmacopeias recommend to capture microorganisms. ATP bioluminescence serves to selectively detect living cells, making this method is highly reliable and consistent with the results of compendial testing methods.

Three-step workflow:

  1. Membrane filtration of the sample and transfer of the membrane filter onto an agar plate for incubation.
  2. Automated application onto the membrane of the reagents needed for the ATP bioluminescence reaction.
  3. Detection & enumeration of microcolonies, computer-based result analysis.

Learn more about the Milliflex® Rapid System 2.0, its technologies, and workflow.

access the Datasheet!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online